Add like
Add dislike
Add to saved papers

The variable MR appearance of primary lymphoma of the central nervous system: comparison with histopathologic features.

PURPOSE: To describe the MR features of primary central nervous system (CNS) lymphoma and to determine whether there is a correlation with histopathologic findings.

METHODS: The MR images, pathologic specimens, and clinical records of 23 patients with primary CNS lymphoma were reviewed. The imaging and pathologic characteristics were tabulated and compared by using the standard tests for association in a two-dimensional contingency table.

RESULTS: A total of 61 lesions were present in 23 patients; 12 patients (52%) had multiple lesions. All lesions were isointense or hypointense on T1-weighted images, and 53% were isointense or hypointense on T2-weighted images. Twenty patients received intravenous contrast material, and 43 (91%) of 47 lesions enhanced. The three patients who had nonenhancing lesions received steroids before the initial MR studies. Enhancement patterns differed between the immunocompetent and the immunocompromised hosts, with the latter group harboring a higher percentage of rim-enhancing lesions. Twenty-seven (44%) of the lesions were centered in a cerebral hemisphere and 14 (23%) were centered in the central gray matter. There was a statistically significant correlation between a higher degree of necrosis histologically and hyperintensity on T2-weighted MR images. The degree of necrosis also showed a positive correlation with rim enhancement.

CONCLUSIONS: Primary CNS lymphoma has a variable MR appearance that correlates with the severity of intratumoral necrosis. These imaging characteristics, as well as lesion location, mean lesion size, and proclivity to harbor necrosis, are altered in the immunocompromised host.

Full text links

We have located links that may give you full text access.
Can't access the paper?
Try logging in through your university/institutional subscription. For a smoother one-click institutional access experience, please use our mobile app.

Related Resources

For the best experience, use the Read mobile app

Mobile app image

Get seemless 1-tap access through your institution/university

For the best experience, use the Read mobile app

All material on this website is protected by copyright, Copyright © 1994-2024 by WebMD LLC.
This website also contains material copyrighted by 3rd parties.

By using this service, you agree to our terms of use and privacy policy.

Your Privacy Choices Toggle icon

You can now claim free CME credits for this literature searchClaim now

Get seemless 1-tap access through your institution/university

For the best experience, use the Read mobile app